Emerging treatment options to improve cardiovascular outcomes in patients with acute coronary syndrome: focus on losmapimod


Autoria(s): Kragholm, K; Newby, LK; Melloni, C
Data(s)

2015

Formato

4279 - 4286

Identificador

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000359300500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92

DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 pp. 4279 - 4286

1177-8881

http://hdl.handle.net/10161/12504

Relação

DRUG DESIGN DEVELOPMENT AND THERAPY

10.2147/DDDT.S69546

Palavras-Chave #p38 MAPK #p38 MAPK inhibitor #losmapimod #safety #efficacy #outcomes
Tipo

Journal Article